RecruitingNCT04880356
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Clinical, Instrumental and Laboratory Data Collection of Subjects with Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Enrollment
100 participants
Start Date
Mar 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age \>= 18 years
- Subjects with ultra-rare inherited degenerative and metabolic neurological diseases
- Subjects with undiagnosed neurological diseases (when supposed to be inherited)
Exclusion Criteria1
- none
Interventions
OTHERcollection of data
collection of retrospective and prospective data from adult patients with ultra-rare inherited neurological diseases
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04880356
Related Trials
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
NCT053181961 location
A Multicenter Pediatric Deep Brain Stimulation Registry
NCT065856181 location
The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
NCT059012591 location
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
NCT065754261 location
Rheopheresis as Adjuvant Treatment of Calciphylaxis
NCT0465400029 locations